Multihance: Clinical Trials

4 trials of Multihance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Multihance: new trials by email Literature Review of Multihance trials Research Report on Multihance

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries
Gadobenate Dimeglumine, Gadopentetate Dimeglumine - Carotid, Aortic, Renal or Peripheral Artery Disease
Phase 3CompletedBracco Diagnostics, Inc1202009-09-012012-01-05
Multihance Versus Magnevist in Breast MRI
Multihance, Magnevist - Breast Cancer
Phase 3CompletedBracco Diagnostics, Inc1302007-07-012010-07-15
Crossover Study With MultiHance vs a Comparator for Peripheral MRA
MultiHance, Magnevist - Peripheral Vascular Disease
Phase 3CompletedBracco Diagnostics, Inc1002006-12-012009-03-27
Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent
Multihance, vasovist - Steno-occlusive Disease
Phase 3CompletedBracco Diagnostics, Inc392006-12-012023-08-01

Conditions studied

Breast Neoplasms (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Vascular Diseases (1)

Sponsors

Bracco Diagnostics, Inc (4)

Countries

Italy (3)  ·  China (1)

Top investigators

Gianpaolo Pirovano, MD (3)

Results publications

PMID 21163915, PMID 23042922